RT Journal Article
SR Electronic
T1 Trends in snakebite deaths in India from 2000 to 2019 in a nationally representative mortality study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.15.20103234
DO 10.1101/2020.05.15.20103234
A1 Suraweera, Wilson
A1 Warrell, David
A1 Whitaker, Romulus
A1 Menon, Geetha R
A1 Rodrigues, Rashmi
A1 Hang Fu, Sze
A1 Begum, Rehana
A1 Sati, Prabha
A1 Piyasena, Kapila
A1 Bhatia, Mehak
A1 Brown, Patrick
A1 Jha, Prabhat
YR 2020
UL http://medrxiv.org/content/early/2020/05/20/2020.05.15.20103234.abstract
AB The World Health Organization call to halve global snakebite deaths by 2030 will requires substantial progress in India. We analyzed 2,833 snakebite deaths from 611,483 verbal autopsies in the nationally representative Indian Million Death Study from 2001–14, and conducted a systematic literature review from 2000–19 covering 87,590 snakebites. We estimate that India had 1.2 million snakebite deaths (average 58,000/year) from 2000–19. Nearly half occurred at ages 30–69 years and over a quarter in children <15 years. Most occurred at home in the rural areas. About 70% occurred in eight higher-burden states and half during the rainy season and at low altitude. The risk of an Indian dying from snakebite before age 70 is about 1 in 250, but notably higher in some areas. More crudely, we estimate 1.11–1.77 million bites in 2015, of which 70% showed symptoms of envenomation. Prevention and treatment strategies might substantially reduce snakebite mortality in India.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot relevant. This study is not a clinical trialFunding StatementUniversity of Toronto (UofT): Prabhat Jha The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData Availability: Data from the Million Death Study (MDS) India cannot be redistributed outside of the Centre for Global Health Research due to legal agreement with the Registrar General of India. However, access to MDS data can be granted via data transfer agreements, upon request to the Office of the Registrar General, RK Puram, New Delhi, India (rgi.rgi@nic.in). The public census reports and Sample Registration data can be accessed thorough http://censusindia.gov.in/. Source data for Figure 1 is already explained in Appendix 3. Source data files have been provided for Figure 2 and for Appendix 1-figure 2. The systematic review data used for Figure 3 is already presented in Appendix 2-table 1.